How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
16
Page:
358-369
Author(s):
Ethan J. Brock, Kyungmin Ji, John J. Reiners and Raymond R. Mattingly
Neuroimmune Crosstalk in CNS Disorders: The Histamine Connection
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
819-848
Author(s):
Ramón Cacabelos, Clara Torrellas, Lucía Fernández-Novoa and Gjumrakch Aliev
MicroRNA-34a and its target genes: Key factors in cancer multidrug resistance
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
933-939
Author(s):
Morteza Ghandadi and Amirhossein Sahebkar
Benzofuran Small Molecules as Potential Inhibitors of Human Protein Kinases. A Review
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
879-894
Author(s):
Halina Kwiecień, Agata Goszczyńska and Paulina Rokosz
Updates on the Production of Therapeutic Antibodies Using Human Hybridoma Technique
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
870-878
Author(s):
Xenia A. Glukhova, Olga V. Prusakova, Julia A. Trizna, Michael M. Zaripov, Gaida V. Afanas’eva, Anatoly S. Glukhov, Rimma A. Poltavtseva, Alexei A. Ivanov, Marco Avila-Rodriguez, George E. Barreto, Gjumrakch Aliev and Igor P. Beletsky
Cadherins: The Superfamily Critically Involved in Breast Cancer
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
616-638
Author(s):
Maeirah Afzal Ashaie and Ezharul Hoque Chowdhury
Susceptibility Risk Alleles of -238G/A, -308G/A and -1031T/C Promoter Polymorphisms of TNF-α Gene to Uterine Leiomyomas
Journal:
Recent Advances in DNA & Gene Sequences (Discontinued)
Volume:
9
Page:
65-71
Author(s):
Veronica Medikare, Altaf Ali, Venkateshwari Ananthapur, Mamata Deendayal and Pratibha Nallari
Emerging Targets For Prostate Adenocarcinoma Therapy: How Molecular Biology May Drive Towards a More Tailored Approach
Journal:
Current Drug Targets
Volume:
17
Page:
266-275
Author(s):
Maria Raffaella Ambrosio, Luigi Pirtoli and Maria Teresa del Vecchio
Predictive Factors of Febrile Neutropenia Induced by Anticancer Chemotherapy in the South of Tunisia
Journal:
Reviews on Recent Clinical Trials
Volume:
11
Page:
72-76
Author(s):
Afef Khanfir, Wala Ben Kridis, Safia Masmoudi, Senda Mezghani, Adnen Hammami and Mounir Frikha
Derivatives of Procaspase-Activating Compound 1 (PAC-1) and their Anticancer Activities
Journal:
Current Medicinal Chemistry
Volume:
23
Page:
201-241
Author(s):
Howard S. Roth and Paul J. Hergenrother